Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice

Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice

The bioactive form of vitamin .D, 1,25-dihydroxyvitamin D (1,25D3), exerts immunomodulatory actions resulting in neuroprotective effects potentially useful against neurodegenerative and autoimmune diseases. In fact, vitamin D deficiency status has been correlated with painful manifestations associat...

Full description

Bibliographic Details
Main Authors:	Nicola Alessio, Carmela Belardo, Maria Consiglia Trotta, Salvatore Paino, Serena Boccella, Francesca Gargano, Gorizio Pieretti, Flavia Ricciardi, Ida Marabese, Livio Luongo, Umberto Galderisi, Michele D’Amico, Sabatino Maione, Francesca Guida
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	International Journal of Molecular Sciences
Subjects:	microglia vitamin D deficiency chronic pain gender palmitoylethanolamide
Online Access:	https://www.mdpi.com/1422-0067/22/7/3604

Similar Items

Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
by: Carmela Belardo, et al.
Published: (2019-04-01)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
by: Serena Boccella, et al.
Published: (2019-04-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
by: Alessio Filippo Peritore, et al.
Published: (2019-09-01)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
by: Alessio Filippo Peritore, et al.
Published: (2020-05-01)

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion
by: Daniela Impellizzeri, et al.
Published: (2019-05-01)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
by: Rosalba Siracusa, et al.
Published: (2020-10-01)

Neuroimmune-Driven Neuropathic Pain Establishment: A Focus on Gender Differences
by: Vincenzo Coraggio, et al.
Published: (2018-01-01)

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01)

Microglia and mast cells: new targets for the treatment of chronic pain
by: V.I. Romanenko
Published: (2021-06-01)

NUMMULAR HEADACHE – THREE YEARS LATER: WHAT HAPPENED
by: Domenico CHIRCHIGLIA, et al.
Published: (2020-03-01)

Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study
by: Walter Gianni, et al.
Published: (2018-05-01)

Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain
by: Francesca Guida, et al.
Published: (2020-05-01)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016-10-01)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
by: Amanda Rao, et al.
Published: (2021-09-01)

Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses
by: S.P. Markey, et al.
Published: (2000-04-01)

EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat
by: Palazzo Enza, et al.
Published: (2011-10-01)

Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects
by: Alessia D’Aloia, et al.
Published: (2021-03-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation
by: Giovanna Casili, et al.
Published: (2020-10-01)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
by: Lucas D. Udovin, et al.
Published: (2020-01-01)

Fatty Acid Amides Synthesized from Andiroba Oil (<i>Carapa guianensis</i> Aublet.) Exhibit Anticonvulsant Action with Modulation on GABA-A Receptor in Mice: A Putative Therapeutic Option
by: Fábio Rodrigues de Oliveira, et al.
Published: (2020-03-01)

Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?
by: Hesselink JMK, et al.
Published: (2016-09-01)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
by: Chirchiglia D, et al.
Published: (2016-07-01)

Focus on the Endogenous Cannabinoid System in Migraine
by: Domenico Chirchiglia, et al.
Published: (2017-08-01)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
by: Chirchiglia D, et al.
Published: (2019-02-01)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
by: Alshelh Z, et al.
Published: (2019-08-01)

PEA/Polydatin: Anti-Inflammatory and Antioxidant Approach to Counteract DNBS-Induced Colitis
by: Alessio Filippo Peritore, et al.
Published: (2021-03-01)

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.
by: Maria Consiglia Trotta, et al.
Published: (2019-01-01)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
by: Ramona D’Amico, et al.
Published: (2021-06-01)

Adenosine Metabotropic Receptors in Chronic Pain Management
by: Livio Luongo, et al.
Published: (2021-04-01)

Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016-03-01)

Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study
by: Jordi Faig-Martí, et al.
Published: (2017-03-01)

Aliamidi e duloxetina nel trattamento del low back pain - Aliamides and duloxetina in the treatment of low back pain
by: Paolo Desio
Published: (2016-01-01)

Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy
by: Julia M. Post, et al.
Published: (2018-03-01)

Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-Acylethanolamine acid amidase
by: Andrea Ghidini, et al.
Published: (2021-01-01)

Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain
by: Marika Cordaro, et al.
Published: (2019-11-01)

Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report
by: Enrico Gugliandolo, et al.
Published: (2020-08-01)